Unravelling the pharmacologic opportunities and future directions for targeted therapies in gastro-intestinal cancers Part 1: GI carcinomas

C Neuzillet, Benoit ROUSSEAU, HM Kocher, P Bourget, C Tournigand,

Pharmacol Tger. 01/06/2017;174 : 145-172 10.1016/j.pharmthera.2017.02.028 14/02/2017

Polymerase proofreading domain mutations: New opportunities for immunotherapy in hypermutated colorectal cancer beyond MMR deficiency

R Bourdais, Benoit ROUSSEAU, A Pujals, H Boussion, C Joly, A Guillemin, I Baumgaertner, C Neuzillet, C Tournigand,

Crit Rev Oncol Hematol. 01/05/2017;113 : 242-248 10.1016/j.critrevonc.2017.03.027. 23/03/2017

PD-L1 expression in perihilar and intrahepatic cholangiocarcinoma

J Fontugne, J Augustin, A Pujals, P Compagnon, Benoit ROUSSEAU, Alain LUCIANI, C Tournigand, D Cherqui, D Azoulay, Jean-Michel PAWLOTSKY, Julien CALDERARO,

Oncotarget 11/04/2017;8(15) : 24644-24651 10.18632/oncotarget.15602.

De novo cancer after solid organ transplantation: Epidemiology, prognosis and management

A Guillemin, Benoit ROUSSEAU, C Neuzillet, C Joly, H Boussion, P Grimbert, P Compagnon, C Duvoux, C Tournigand,

Bull Cancer 01/03/2017;104(3) : 245-257 10.1016/j.bulcan.2016.12.008. 23/02/2017

Predictive factors of renal toxicities related to anti-VEGFR multikinase inhibitors in phase 1 trials

E Boissier, O Mir, A Hollebecque, H Izzedine, S Ederhy, A Gazzah, R Bahleda, C Massard, I Macquin-Mavier, C Tournigand, JP Spano, JC Soria, Benoit ROUSSEAU,

Invest New Drugs. 01/02/2017;35(1) : 79-86 10.1007/s10637-016-0402-3 25/10/2016

Programmed death ligand 1 expression in hepatocellular carcinoma: Relationship With clinical and pathological features.

Julien CALDERARO, Benoit ROUSSEAU, Giuliana AMADDEO, M Mercey, C Charpy, CE Costentin, Alain LUCIANI, ES Zafrani, A Laurent, D Azoulay, Fouad LAFDIL, Jean-Michel PAWLOTSKY,

Hepatology 01/12/2016;64(6) : 2038-2046 10.1002/hep.28710. 09/08/2016

First-line antiangiogenics for metastatic renal cell carcinoma: A systematic review and network meta-analysis

Benoit ROUSSEAU, E Kempf, G Desamericq, E Boissier, M Chaubet-Houdu, C Joly, C Saldana, H Boussion, C Neuzillet, I Macquin-Mavier, S Oudard, L Salomon, A de la Taille, C Tournigand,

Crit Rev Oncol Hematol. 01/11/2016;107 : 44-53 10.1016/j.critrevonc.2016.08.012. 01/09/2016

Are cancer outpatients ready for e-medicine?

E Kempf, A Prevost, Benoit ROUSSEAU, I Macquin-Mavier, A Louvet, C Tournigand,

Bull Cancer 01/10/2016;103(10) : 841-848 10.1016/j.bulcan.2016.06.004 03/08/2016

Acute neurovascular events in cancer patients receiving anti-vascular endothelial growth factor agents: Clinical experience in Paris University Hospitals

C Tlemsani, O Mir, D Psimaras, Y Vano, M Ducreux, B Escudier, Benoit ROUSSEAU, D Loirat, B Ceccaldi, P Andre, F Goldwasser, D Ricard,

Eur J Cancer 01/10/2016;66 : 75-82 10.1016/j.ejca.2016.07.008. 15/08/2016

Severe hyponatremia caused by nab-paclitaxel-induced syndrome of inappropriate antidiuretic hormone secretion: A case report in a patient with metastatic pancreatic adenocarcinoma

C Neuzillet, S Babai, E Kempf, G Pujol, Benoit ROUSSEAU, H Le-Louet, C Tournigand,

Medicine (Baltimore) 01/06/2016;95(26) : e4006 10.1097/MD.0000000000004006.